What price can we apply to a company relying solely on a “buy back” as its primary business model to raise a stagnated SP for “just a couple more years” when maybe at that time sales for vitiligo might occur?
Food for Thought, page-19
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.65 |
Change
0.420(2.76%) |
Mkt cap ! $761.5M | |||
| Open | High | Low | Value | Volume |
| $15.45 | $15.69 | $15.18 | $333.8K | 21.52K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 32 | $15.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.67 | 108 | 3 |
View Market Depth
| Last trade - 12.05pm 25/06/2024 (20 minute delay) ? |
| CUV (ASX) Chart |